Macular Pucker Clinical Trial
— ELPOfficial title:
Vergelijking Van de Postoperatieve Effectieve Lenspositie (ELP) Bij patiënten Gepland Voor Een Electieve Phacovitrectomie-ingreep (Phaco-VTX) Aan één Oog en Enkel Een Lensingreep Phaco Aan Het Andere Oog
NCT number | NCT04397068 |
Other study ID # | S58904 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | March 1, 2016 |
Est. completion date | March 31, 2017 |
Verified date | May 2020 |
Source | Universitaire Ziekenhuizen Leuven |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of the study is to gain more insight into the potential impact of a vitrectomy (removal of the vitreous) on postoperative effective position of the intraocular lens (IOL). Moreover, this study can provide very useful information for the optimal lens calculation in patients undergoing lens extraction with IOL implantation (whether or not combined with a vitrectomy) should undergo.
Status | Completed |
Enrollment | 20 |
Est. completion date | March 31, 2017 |
Est. primary completion date | March 31, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 50 Years and older |
Eligibility |
Inclusion Criteria: - age > 50 yrs - macular pucker wherefore vitrectomy is necessary Exclusion Criteria: - macular pathology other than macular pucker - Corneal pathology - Other ocular pathology that could affect the biometrics or ELP - Previous vitrectomy in one of the eyes |
Country | Name | City | State |
---|---|---|---|
Belgium | Universitaire Ziekenhuizen Leuven | Leuven |
Lead Sponsor | Collaborator |
---|---|
Universitaire Ziekenhuizen Leuven |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Compare if ELP is different or the same at phaco or phaco-vitrectomy | Anterior chamber depth measured using IOL master. | 6 - 8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT01969929 -
Comparison of Postoperative Aqueous Flare After 20G Versus 23G Pars Plana Vitrectomy
|
N/A | |
Completed |
NCT00555269 -
Membrane Blue Versus Infracyanine Green
|
N/A | |
Completed |
NCT03934190 -
Inner Nuclear Macular Microcyst is a Risk Factor for Macular Cystoid Changes After Phacoemulsification in Eyes With Previous Vitrectomy and Macular Pucker Removal
|
||
Terminated |
NCT04802265 -
EpiRetinal Membrane Peeling and Internal Limiting Membrane
|
||
Completed |
NCT02319655 -
Morphologic Changes After Membrane Peeling With Air Tamponade and Balanced Salt Solution
|
N/A | |
Completed |
NCT05517473 -
Efficacy and Safety Evaluation of MONOBLUE DUAL View and MONOBLUE ILM View Vital Stains
|
||
Completed |
NCT01162356 -
Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) Study
|
N/A | |
Recruiting |
NCT01083004 -
Brilliant Blue Versus Indocyanine Green
|
Phase 3 | |
Recruiting |
NCT04802915 -
Intraoperative Analysis of the Central Retina in ERF
|
N/A | |
Recruiting |
NCT04501367 -
Assessing the Efficacy and Safety fo DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert(s) for the Treatment of Pain, Inflammation, and Cystoid Macular Edema Following 27 Gauge Vitrectomy With Internal Limiting Membrane Peel for the Treatment of Retinal Edema Associated With Macular Pucker.
|
Phase 4 | |
Recruiting |
NCT05860985 -
Zeiss RESIGHT Disposable Lenses Evaluation Study
|
N/A |